"Trust Issues and Hot Trends: Key Takeaways from JPMorgan Healthcare Conference 2024"
TL;DR Summary
At the J.P. Morgan Healthcare Conference, Recursion, a biotech firm using AI for drug development, made a splash with AI-driven drug discovery software in collaboration with Nvidia, as the tech giant's stock soars due to AI expectations. The event showcased AI's potential, but skepticism remains as not everyone is ready to embrace its impact on healthcare.
- AI generated plenty of interest at JPM but not a lot of trust STAT
- What's Hot at JPM's Health Conference | Odd Lots Bloomberg Podcasts
- Optimistic, but for how long? Our big takeaways from #JPM2024 BioSpace
- Five Major Themes From The 2024 J.P. Morgan Healthcare Conference Forbes
- Jim Cramer's 4 stock ideas from JPMorgan Healthcare Conference CNBC
Reading Insights
Total Reads
0
Unique Readers
8
Time Saved
1 min
vs 2 min read
Condensed
73%
205 → 56 words
Want the full story? Read the original article
Read on STAT